MARKET

SIGA

SIGA

SIGA Tech
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.67
-0.03
-0.53%
After Hours: 5.67 0 0.00% 16:00 09/19 EDT
OPEN
5.70
PREV CLOSE
5.70
HIGH
5.81
LOW
5.63
VOLUME
104.13K
TURNOVER
--
52 WEEK HIGH
8.09
52 WEEK LOW
4.680
MARKET CAP
459.53M
P/E (TTM)
1.061
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of SIGA and other stocks commission-free!

Open a Webull account and fund it to get a free stock

SIGA News

  • SIGA to Present at the 14th Annual Wells Fargo Securities Healthcare Conference on September 5, 2019
  • GlobeNewswire.08/28 12:30
  • SIGA awarded $19.5M contract for development of TPOXX
  • seekingalpha.07/08 18:35
  • SIGA Awarded Department of Defense Contract to Develop Expanded Indication for TPOXX® as Post-Exposure Prophylactic for Smallpox
  • GlobeNewswire.07/08 11:30
  • Hedge Funds Have Never Been This Bullish On SIGA Technologies Inc. (SIGA)
  • Insider Monkey.06/27 15:18

More

Industry

Biotechnology & Medical Research
+0.06%
Pharmaceuticals & Medical Research
+0.42%

Hot Stocks

Name
Price
%Change

About SIGA

SIGA Technologies, Inc. is engaged in the development and commercialization of solutions for various unmet medical needs and biothreats. The Company's lead product is TPOXX, an orally administered antiviral drug that targets orthopoxviruses infections. TPOXX is a small-molecule drug delivered to the Strategic Stockpile under the Project BioShield Act of 2004 (Project BioShield). TPOXX is an investigational product that is not approved by the United States Food and Drug Administration (FDA) as a treatment of smallpox or any other indication. The Company relies on and uses third parties known as contract manufacturing organizations (CMOs) to procure commercial raw materials and supplies, and to manufacture TPOXX. The Company identified a lead pre-clinical drug candidate with activity against four serotypes of the virus and which has shown efficacy in a murine model of disease.
More

Webull offers SIGA Technologies, Inc. (SIGA) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.